glp-1 intestinal paralysis lawyer in west virginia medications were first introduced to regulate diabetes, but recently the conversation around these medications has been centered around its accessibility and impact on body image glp-1 stomach paralysis lawsuit in

GLP-1 was identified as a key incretin hormone in the 1980 s (Lund et al

Re-evaluate hormones

These agents are also associated with a minimal risk of hypoglycemia when used as monotherapy or as add-on to metformin monotherapy, but they can contribute to hypoglycemia when used in combination with medications associated with hypoglycemia, such as insulin and insulin secretagogues

81 FornesAHuffJPritchardRIGodfreyM

resources, H.A.L

The most common reasons include: Gastrointestinal side effects such as nausea, vomiting and diarrhea which are the single most frequently documented reason for stopping in large health system datasets High out of pocket cost and lack of insurance coverage particularly in individuals without diabetes Medication unavailability or pharmacy supply shortages which peaked in 2023early 2024 Perceived completion of therapy once target weight is reached or weight loss plateaus Concerns about long term safety or treatment burden of injections Many cohorts show substantial discontinuation by 3 months, with further losses by 6-9 months